Form 4: Vertex Pharmaceuticals Inc / Ma Director Receives Stock Gran
Insider Transaction (Form 4)
Daniel J. Brennan, a Director of Vertex Pharmaceuticals Inc / Ma, received 795 shares of common stock on October 20, 2026.
Summary
- Grant/award: acquired 795 Common Stock at $503.47 ($400,259) on October 20, 2026; holds 795 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Daniel J. Brennan — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-20 | Grant/award | Common Stock | 795 | $503 | $400.3K | 795 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-20 | Grant/award (795 shares) |
Keywords
insider transaction, Form 4, VRTX, VERTEX PHARMACEUTICALS INC / MA, neutral, Daniel J. Brennan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.